Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01654198 · ClinicalTrials.gov registry record
PET/CT in Psoriatic Arthritis
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 12
- Enrollment target
NCT01654198: Completed study, sponsored by University of Pennsylvania.
NCT01654198 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01654198 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
When patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA). At this time, doctors use information from the history and physical exam to determine the diagnosis. X-rays, magnetic resonance imaging (MRI) and ultrasound have been used to help with the diagnosis but all three have limitations. A newer imaging technique, whole body Positron Emission Tomography/Computed Tomography (PET/CT) uses the idea that inflammatory cells take up sugar to locate inflammation in the body. Because patients with PsA have inflammatory cells in their joints and tendons, this type of scan allows the physician to take a picture of the whole body and locate inflammation. The investigators have found that some patients with psoriasis (but without arthritis) have inflammation in joints and tendons even before the patient has symptoms. In this study, the investigators will explore how well PET/CT works for assessing inflammation in patients with PsA. This would be a very exciting tool that could be used to find and treat inflammation before it causes damage or pain.
Interventions
- RADIATION FDG-PET/CT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2018-10-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01654198
The ClinicalTrials.gov registry entry for NCT01654198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG-PET/CT scan is the first listed.
NCT01654198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01654198 about?
NCT01654198 is a clinical study titled "PET/CT in Psoriatic Arthritis". When patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA). At this time, doctors use information from the history and physical exam to determine the diagnosis. X-rays, magnetic resonance imaging (MRI) and ultrasound have b...
What is the current status of trial NCT01654198?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2018-10-02.
What interventions are being tested in trial NCT01654198?
The interventions under investigation include: FDG-PET/CT scan (RADIATION).
Who is sponsoring clinical trial NCT01654198?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.